CBIO

Crescent Biopharma Inc

Jun 05 • 04:00PM ET

18.00

-0.45 -2.44 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: INCY BMRN VKTX KRYS KYMR NUVL RYTM AXSM MDGL NBIX

| Held by: VTI VXF AVSC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-12.48	Insider Own	21.45%	Shs Outstand	27.57M	Perf Week	-12.83%
Market Cap	496.29M	Forward P/E	-	EPS next Y	-3.25	Insider Trans	29.86%	Shs Float	21.66M	Perf Month	-0.33%
Enterprise Value	312.67M	PEG	-	EPS next Q	-0.78	Inst Own	78.98%	Short Float	13.39%	Perf Quarter	49.13%
Income	-162.08M	P/S	41.78	EPS this Y	75.02%	Inst Trans	7.61%	Short Ratio	10.60	Perf Half Y	34.23%
Sales	11.88M	P/B	2.76	EPS next Y	-1.49%	ROA	-158.03%	Short Interest	2.90M	Perf YTD	51.77%
Book/sh	6.52	P/C	2.62	EPS next 5Y	35.34%	ROE	-173.14%	52W High	27.41 -34.33%	Perf Year	-9.37%
Cash/sh	6.86	P/FCF	-	EPS past 3/5Y	45.01% 33.26%	ROIC	-87.64%	52W Low	8.72 106.42%	Perf 3Y	-91.04%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	424.86% 1.31%	Gross Margin	98.75%	Volatility	10.24% 10.74%	Perf 5Y	-93.08%
Dividend TTM	-	EV/Sales	26.32	EPS Y/Y TTM	72.70%	Oper. Margin	-1372.85%	ATR (14)	2.04	Perf 10Y	-97.99%
Dividend Ex-Date	-	Quick Ratio	13.78	Sales Y/Y TTM	-100.00%	Profit Margin	-1363.94%	RSI (14)	44.37	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	13.78	EPS Q/Q	78.91%	SMA20	-7.19%	Beta	1.18	Target Price	29.50
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-8.99%	Rel Volume	0.70	Prev Close	18.45
Employees	44	LT Debt/Eq	0.01	Earnings	Apr 29 AMC	SMA200	27.43%	Avg Volume	273.80K	Price	18.00
IPO	Jan 10, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	20.33% 180.03%	Trades		Volume	192,619	Change	-2.44%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)